CODX Long Call Strategy
CODX (Co-Diagnostics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
CODX (Co-Diagnostics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.7M, a beta of 2.88 versus the broader market, a 52-week range of 1.26-46.5, average daily share volume of 5.8M, a public-listing history dating back to 2017, approximately 115 full-time employees. These structural characteristics shape how CODX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.88 indicates CODX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on CODX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
CODX snapshot
As of August 14, 2026, spot at $1.42, ATM IV 35.20%, IV rank 4.05%, expected move 10.09%. The long call on CODX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.
Why this long call structure on CODX specifically: CODX IV at 35.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a CODX long call, with a market-implied 1-standard-deviation move of approximately 10.09% (roughly $0.14 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CODX expiries trade a higher absolute premium for lower per-day decay. Position sizing on CODX should anchor to the underlying notional of $1.42 per share and to the trader's directional view on CODX stock.
CODX long call setup
The CODX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CODX at $1.42 on that close, the first option leg uses a $1.42 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CODX chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CODX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.42 | N/A |
CODX long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CODX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CODX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on CODX
Long calls on CODX express a bullish thesis with defined risk; traders use them ahead of CODX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CODX thesis for this long call
The market-implied 1-standard-deviation range for CODX extends from approximately $1.28 on the downside to $1.56 on the upside. A CODX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CODX IV rank near 4.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CODX at 35.20%. As a Healthcare name, CODX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CODX-specific events.
CODX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CODX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CODX alongside the broader basket even when CODX-specific fundamentals are unchanged. Long-premium structures like a long call on CODX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CODX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CODX?
- A long call on CODX is the long call strategy applied to CODX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CODX stock at $1.42 on the most recent close, the strikes shown on this page are snapped to the nearest listed CODX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CODX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CODX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 35.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CODX long call?
- The breakeven for the CODX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CODX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CODX?
- Long calls on CODX express a bullish thesis with defined risk; traders use them ahead of CODX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CODX implied volatility affect this long call?
- CODX ATM IV is at 35.20% with IV rank near 4.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.